Xuefang Liu

Xuefang Liu

Auto-generated profile, based on publicly available information

Xuefang Liu

Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou, Henan 450046, P.R. China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

17 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
RLRong-Rong Li
Rong-Rong Li
XLXue-Fang Liu
Xue-Fang Liu
SFSuXiang Feng
SuXiang Feng
SSSheng-Nan Shu
Sheng-Nan Shu
PWPei-Yang Wang
Pei-Yang Wang
LQLing-Bo Qu
Ling-Bo Qu
(1) Background: Rhubarb anthraquinones—a class of components with neuroprotective function—can be used to alleviate cerebral ischemia reperfusion injury. (2) Methods: The three pharmacodynamic indicators are neurological function score, brain water content, and cerebral infarction area; UPLC-MS/MS was used in pharmacokinetic studies to detect plasma concentrations at different time points, and DAS software was used to calculate pharmacokinetic parameters in a noncompartmental model. (3) Results: The results showed that the pharmacodynamics and pharmacokinetics of one of the five anthraquinone aglycones could be modified by the other four anthraquinones, and the degree of interaction between different anthraquinones was different. The chrysophanol group showed the greatest reduction in pharmacodynamic indicators comparing with other four groups where the rats were administered one of the five anthraquinones, and there was no significant difference between the nimodipine group. While the Aloe-emodin + Physcion group showed the most obvious anti-ischemic effect among the groups where the subjects were administered two of the five anthraquinones simultaneously. Emodin, rhein, chrysophanol, and physcion all increase plasma exposure levels of aloe-emodin, while aloe-emodin lower their plasma exposure levels. (4) Conclusions: This experiment provides a certain preclinical basis for the study of anthraquinone aglycones against cerebral ischemia and a theoretical basis for the study of the mechanism of interaction between anthraquinones.

8 May 2020 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
JWJing Wang
Jing Wang
YLYa Li
Ya Li
PZPeng Zhao
Peng Zhao
YTYange Tian
Yange Tian
XLXuefang Liu
Xuefang Liu
JLJiansheng Li
Jiansheng Li
Particulate matter with an aerodynamic diameter equal or less than 2.5 micrometers (PM2.5) is associated with the development of chronic obstructive pulmonary disease (COPD). The mechanisms by which PM2.5 accelerates disease progression in COPD are poorly understood. In this study, we aimed to investigate the effect of PM2.5 on lung injury in rats with hallmark features of COPD. Cardinal features of human COPD were induced in a rat model by repeated cigarette smoke inhalation and bacterial infection for 8 weeks. Then, from week 9 to week 16, some of these rats with COPD were subjected to real-time concentrated atmospheric PM2.5. Lung function, pathology, inflammatory cytokines, oxidative stress, and mucus and collagen production were measured. As expected, the COPD rats had developed emphysema, inflammation, and deterioration in lung function. PM2.5 exposure resulted in greater lung function decline and histopathological changes, as reflected by increased Mucin (MUC) 5ac, MUC5b, Collagen I, Collagen III, and the profibrotic cytokine α-smooth muscle-actin (SMA), transforming growth factor- (TGF-) β1 in lung tissues. PM2.5 also aggravated inflammation, increasing neutrophils and eosinophils in bronchoalveolar lavage fluid (BALF) and cytokines including Interleukin- (IL-) 1β, granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-4. The likely mechanism is through oxidative stress as antioxidants levels were decreased, whereas oxidants were increased, indicating a detrimental shift in the oxidant-antioxidant balance. Altogether, these results suggest that PM2.5 exposure could promote the development of COPD by impairing lung function and exacerbating pulmonary injury, and the potential mechanisms are related to inflammatory response and oxidative stress.


10 September 2020 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
JLJiansheng Li
Jiansheng Li
YQYanqin Qin
Yanqin Qin
YCYulong Chen
Yulong Chen
PZPeng Zhao
Peng Zhao
XLXuefang Liu
Xuefang Liu
CLCongcong Li
Congcong Li
The interaction between alveolar epithelial cells (EpCs) and macrophages (MPs) serves an important role in initiating and maintaining inflammation in chronic pulmonary diseases. The aim of the present study was to investigate the molecular mechanisms of the inflammatory response in co‑cultured EpCs and MPs. Briefly, a co‑culture system of A549 (EpCs) and THP‑1 (monocyte/MPs) cells was established in a filter‑separated Transwell plate to evaluate the inflammatory response. Following lipopolysaccharide (LPS) treatment, cytokine levels were measured using ELISAs, NF‑κB transcription factor activity was detected using EMSA and protein expression levels were analyzed using Western blot assays subsequently in EpCs and MPs. Co‑cultured EpCs/MPs were found to secrete increased levels of interleukin (IL)‑6, IL‑1β, IL‑8 and tumor necrosis factor (TNF)‑α following LPS exposure for 6, 12, 24 and 48 h compared with either EpC or MP monocultures. Concurrently, NF‑κB was revealed to be activated in MPs at 6 and 12 h, and in EpCs at 24 h. NF‑κB DNA binding, Toll‑like receptor 4 expression levels and the p65 phosphorylation status were also increased, which may contribute to the inflammatory response in the EpC/MP co‑cultures. Notably, cytokine levels decreased following the inhibition of NF‑κB expression with pyrrolidinedithiocarbamate. In conclusion, the present study successfully established an EpC/MP co‑culture system using LPS, which may be a useful model for studying chronic inflammation in vitro.

1 July 2020 in Journal of Integrative Medicine
Verified
Journal Article
Closed access
JLJiansheng Li
Jiansheng Li
XLXue-Fang Liu
Xue-Fang Liu
HDHao-Ran Dong
Hao-Ran Dong
WZWan-Chun Zheng
Wan-Chun Zheng
SFSuXiang Feng
SuXiang Feng
YXYang Xie
Yang Xie